Author

E. Pyne

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. W. Beavis· 1 shared C. J. Cawthorne· 1 shared H. Moody· 1 shared I. M. Pires· 1 shared I. Renard· 1 shared R. Roy· 1 shared S. D. Edge· 1 shared S. G. Maher· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. W. Beavis

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PI3K inhibition as a novel therapeutic strategy for neoadjuvant chemoradiotherapy resistant oesophageal adenocarcinoma

S. D. Edge, I. Renard, E. Pyne, H. Moody, R. Roy, A. W. Beavis, S. J. Archibald, C. J. Cawthorne, S. G. Maher, I. M. Pires

This study shows that PI3K inhibition improves radiation response in oesophageal adenocarcinoma patients resistant to neo-CRT by upregulating PTEN through miR-187.

The British Journal of Radiology · Mar 1, 2021Peer-reviewedCancer Biology